| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-08 |